• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

OMRF is an independent, nonprofit biomedical research institute dedicated to discoveries that make a difference.

  • About
    • General Information
    • Disease Research
    • Education & Outreach
    • Events
    • Careers
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • News Releases
    • Publications
    • On Your Health
    • Bodywork
  • Patients
    • Anti-Aging Studies
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Disease
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • MS Advocate Challenge
    • Tax Credit
    • Planned Giving
    • Vehicle Donations
    • Why We Give
    • Your Gift at Work
    • Donor Recognition
    • Contact Development
Home - OMRF News - Archives for treatment

treatment

Guthridge, Joel

Oblato acquires all rights to glioblastoma drug from OMRF

October 29, 2018

Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.

Filed Under: News, Technology Ventures News Tagged With: 007, americans, brain, cancer, clinical, deadly, diagnosis, drug, edward kennedy, Gtree, james battiste, john mccain, Manu Nair, mike schuster, model, news, Norman, Oblato, Oklahoma Medical Research Foundation, okn, OKN-007, OMRF, Rheal, rheal towner, robert floyd, scientist-news, Stephenson Cancer Center, technology, testing, therapy, Towner, treatment, trial, tumor, university of oklahoma

OMRF receives $2.8 million grant to study rare disorder

August 23, 2018

The grant will provide Bob Axtell with $2.8 million to study NMO and investigate its similarities to other autoimmune diseases, particularly MS.

Filed Under: News Tagged With: allergy, approved, autoimmune, Axtell, Bob Axtell, brain stem, consequences, develop, disease, infectious diseases, interferon, interferon beta, lupus, multiple sclerosis, National Institutes of Health, neuromyelitis optica, new, news, newsok, NIAID, NIH, NMO, OKC, Oklahoma Medical Research Foundation, OMRF, option, robert, Robert Axtell, scientist-news, therapy, treatment

Joint interest: Understanding different types of arthritis

July 10, 2018

Arthritis is the leading cause of disability in the U.S., but it isn’t just one disease.

Filed Under: News Tagged With: arthritis, autoimmune, back, cartilage, cause, Chakravarty, clinical trial, conditions, cure, difficulty, disability, disease, distinct, Eliza, eliza chakravarty, fingers, hips, immune system, joint, knees, lab, newsok, oa, obesity, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, osteoarthritis, pain, ra, research, rheumatoid arthritis, risk, science, scientist-news, StopRA, trauma, treat, treatment

Discovery could help treat Tylenol overdoses

June 12, 2018

New research from OMRF has pinpointed the cause of liver bleeding during acetaminophen overdose, as well as a possible treatment.

Filed Under: News Tagged With: acetaminophen, apap, bleeding, cells, Courtney, courtney griffin, damage, drugs, FDA, Florea, Griffin, hepatology, journal, liver, Lupu, metabolized, National Institutes of Health, NIGMS, NIH, od, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, overdose, percocet, plasmin, scientist-news, siqi gao, therapy, tranexamic acid, treatment, tylenol, vicodin

Experts propose improving clinical trials for lupus

April 23, 2018

The goal of the new white paper is to create a dramatic shift in how lupus clinical trials are conducted so effective treatments can stand a chance to succeed.

Filed Under: News Tagged With: autoimmune disease, barriers, clinical, clinical trials, design, develop, drugs, effort, FDA, illness, immonology, James, Joan, Joan Merrill, Judith, Judith James, lfa, lupus, Lupus Foundation of America, medicine, Merrill, new, Oklahoma Medical Research Foundation, OMRF, projects, research, scientist-news, specialists, therapies, treatment, us, white paper

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 4
  • Go to page 5
  • Go to page 6
  • Go to page 7
  • Go to page 8
  • Go to Next Page »

Before Footer

EEO/AA Employer/Vet/Disabled

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Intranet
Facebook Twitter Instagram Linkedin

Subscribe to OMRF News
  • Contact
  • Careers
  • Donor Privacy
  • Intranet
OMRF Logo
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13th St.
Oklahoma City, OK 73104
(405) 271-6673
Charity navigatorUnited WayGive Smart OKCTop Workplace